|
See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
My Account
Join us! · InformexUSA 2012 · New Orleans, Louisiana ·
February 14-17, 2012
· Booth 2514
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description
Tacrine is an amino acridine compound that inhibits acetylcholinesterase (AChE), and has been proposed as a clinical treatment for Alzheimer’s disease.1 bis(7)-
1 Giacobini, E. Cholinesterase inhibitors for Alzheimer’s disease therapy: From tacrine to future applications. Neurochem Int 32 413-419 (1998).
2
Carlier, P.R., Han, Y.F., Chow, E.S.H., et al. Evaluation of short-
3
Hong, W., Carlier, P.R., Wing-Lok, H., et al. Attenuation of scopolamine-
Background ReadingCarlier, P.R., Han, Y.F., Chow, E.S.H., et al. Evaluation of short- Giacobini, E. Cholinesterase inhibitors for Alzheimer’s disease therapy: From tacrine to future applications. Neurochem Int 32 413-419 (1998). Hong, W., Carlier, P.R., Wing-Lok, H., et al. Attenuation of scopolamine- bis(7)-Tacrine is available in the following screening library:
|
This product is available in custom sizes and/or larger quantities. Please contact our Sales Department for a quote or to purchase. Pricing updated 2012-02-12. Prices are subject to change without notice. To ask for assistance with one of our products please contact a Technical Support Scientist. Warning This product is not for human or veterinary use. Related Products
Downloads
Batch-specific InformationLogin to access batch-specific information
|
Cayman Chemical is a manufacturer, supplier and vendor of biochemical reagents, assay kits, antibodies, and proteins. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640 Copyright 2012 Cayman Chemical Company | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||